Introduction: An inguinal hernia is frequently identified in men with prostate cancer, which is likely due to similar risk factors, including age, gender and smoking.
Aim: To assess the safety and feasibility of performing concomitant robotic-assisted radical prostatectomy (RARP) and robotic-assisted transabdominal preperitoneal (TAPP) inguinal hernia repair.
Materials and methods: We retrospectively analyzed the treatment outcomes of 23 patients who underwent RARP between January 2022 and June 2023. All patients underwent RARP and robotic-assisted TAAP inguinal hernia repair using a polypropylene mesh implant.
Results: The mean age was 70 years. Median prostate volume and preoperative prostate-specific antigen (PSA) were 52 ml and 8.0 ng/ml, respectively. In all cases the procedure was successful. The mean total duration of RARP and inguinal hernia repair was 147.17 and 26.01 minutes, respectively. The mean estimated blood loss and length of hospital stay was 171.96 mL and 7 days, respectively. In nine cases there was Clavien-Dindo grade 1 complications in the postoperative period; all complications were resolved conservatively. At a median follow-up of 12 months, there were no cases of mesh infection, seroma formation, or inguinal pain.
Conclusions: Our results confirm the safety and feasibility of simultaneous RARP and robot-assisted TAPP inguinal hernia repair.
Keywords: inguinal hernia; prostate cancer; radical prostatectomy; robot-assisted prostatectomy; robotic inguinal hernia repair; simultaneous surgery.